Product Description: 5-HT2B antagonist-2 (Compound 19c) is a 5HT2B receptor antagonist with an IC50 of 1.09 nM. 5-HT2B antagonist-2 can downregulate the expression of fibrosis-related genes α-SMA, Timp1, Col1a1, and Col3a1, and significantly reduce the deposition of fibrosis, thereby reducing the fibrotic area and inhibiting the fibrotic process in CCl4-induced liver fibrosis mouse models. 5-HT2B antagonist-2 can be used in the study of immune inflammatory-related diseases, particularly in the research of pulmonary fibrosis diseases[1].
Formula: C23H28Cl2N4O7S
References: [1]Yoon J, et al. Synthesis and Biological Evaluation of Peripheral 5HT2B Antagonists for Liver Fibrosis. J Med Chem. 2025 Mar 6.
Molecular Weight: 575.46
Research Area: Cancer
Target: 5-HT Receptor